关注
David Lechuga-Ballesteros
David Lechuga-Ballesteros
Research Fellow, AstraZeneca Pharmaceuticals, Ltd
在 astrazeneca.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Particle formation in spray drying
R Vehring, WR Foss, D Lechuga-Ballesteros
Journal of aerosol science 38 (7), 728-746, 2007
7862007
Dry powder compositions having improved dispersivity
M Kuo, D Lechuga-Ballesteros
US Patent 6,518,239, 2003
2772003
Trileucine improves aerosol performance and stability of spray‐dried powders for inhalation
D Lechuga‐Ballesteros, C Charan, CLM Stults, CL Stevenson, DP Miller, ...
Journal of pharmaceutical sciences 97 (1), 287-302, 2008
2142008
Phase transition and heterogeneous/epitaxial nucleation of hydrated and anhydrous theophylline crystals
N Rodríguez-Hornedo, D Lechuga-Ballesteros, HJ Wu
International journal of pharmaceutics 85 (1-3), 149-162, 1992
1491992
Heat-stable measles vaccine produced by spray drying
S Ohtake, RA Martin, L Yee, D Chen, DD Kristensen, ...
Vaccine 28 (5), 1275-1284, 2010
1472010
Optimisation of powders for pulmonary delivery using supercritical fluid technology
M Rehman, BY Shekunov, P York, D Lechuga-Ballesteros, DP Miller, ...
European journal of pharmaceutical sciences 22 (1), 1-17, 2004
1362004
Physical stability of salmon calcitonin spray-dried powders for inhalation
HK Chan, AR Clark, JC Feeley, MC Kuo, SR Lehrman, K Pikal-Cleland, ...
Journal of pharmaceutical sciences 93 (3), 792-804, 2004
1352004
Improvement of the dispersibility of spray-dried budesonide powders using leucine in an ethanol–water cosolvent system
MA Boraey, S Hoe, H Sharif, DP Miller, D Lechuga-Ballesteros, R Vehring
Powder technology 236, 171-178, 2013
1322013
Pharmaceutical liquid crystals: the relevance of partially ordered systems
CL Stevenson, DB Bennett, D Lechuga-Ballesteros
Journal of pharmaceutical sciences 94 (9), 1861-1880, 2005
1232005
Cosuspensions of microcrystals and engineered microparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers
R Vehring, D Lechuga-Ballesteros, V Joshi, B Noga, SK Dwivedi
Langmuir 28 (42), 15015-15023, 2012
1142012
Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility
C Bhugra, S Rambhatla, A Bakri, SP Duddu, DP Miller, MJ Pikal, ...
Journal of pharmaceutical sciences 96 (5), 1258-1269, 2007
1022007
Solid-state behavior of cromolyn sodium hydrates
LR Chen, VG Young Jr, D Lechuga-Ballesteros, DJW Grant
Journal of pharmaceutical sciences 88 (11), 1191-1200, 1999
941999
Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines
S Ohtake, R Martin, A Saxena, B Pham, G Chiueh, M Osorio, D Kopecko, ...
Vaccine 29 (15), 2761-2771, 2011
922011
Aerosolizable formulation comprising nicotine
D Lechuga-Ballesteros, M Kuo, Y Song, B Bueche
US Patent App. 11/169,153, 2006
922006
Single emulsion-solvent evaporation technique and modifications for the preparation of pharmaceutical polymeric nanoparticles
M G Nava-Arzaluz, E Piñón-Segundo, A Ganem-Rondero, ...
Recent patents on drug delivery & formulation 6 (3), 209-223, 2012
882012
The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state
AM Abdul‐Fattah, D Lechuga‐Ballesteros, DS Kalonia, MJ Pikal
Journal of pharmaceutical sciences 97 (1), 163-184, 2008
812008
Absorption of polyethylene glycol (PEG) polymers: the effect of PEG size on permeability
H Gursahani, J Riggs-Sauthier, J Pfeiffer, D Lechuga-Ballesteros, ...
Journal of pharmaceutical sciences 98 (8), 2847-2856, 2009
752009
Microcalorimetric measurement of the interactions between water vapor and amorphous pharmaceutical solids
D Lechuga-Ballesteros, A Bakri, DP Miller
Pharmaceutical research 20, 308-318, 2003
742003
Properties and stability of a liquid crystal form of cyclosporine—the first reported naturally occurring peptide that exists as a thermotropic liquid crystal
D Lechuga-Ballesteros, A Abdul-Fattah, CL Stevenson, DB Bennett
Journal of pharmaceutical sciences 92 (9), 1821-1831, 2003
722003
Drug delivery from an innovative LAMA/LABA co-suspension delivery technology fixed-dose combination MDI: evidence of consistency, robustness, and reliability
A Doty, J Schroeder, K Vang, M Sommerville, M Taylor, B Flynn, ...
AAPS PharmSciTech 19, 837-844, 2018
672018
系统目前无法执行此操作,请稍后再试。
文章 1–20